April 24, 2024Other news to note for April 24, 2024Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aubex, Bighat, Biolojic, Endo, Exopharm, Glysious, J&J, Hami, Merck & Co., Moderna, Openai, Nektar, Tetra, Tryp, Tryptamine, Vivoryon.
April 24, 2024Other news to note for April 24, 2024Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Blue Arbor, Cortechs.ai, Genembryomics, Progenesis, Scibase.
April 23, 2024Other news to note for April 23, 2024Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Apotex, Benevolentai, Daré, Escient, ICER, Immedica, Incyte, GSK, Merck KGaA, Oncimmune, OSR, Palisade, Paxmedica, Profluent, Red Light, Sillajen, Strand, Teva, Tharimmune, Vanda, Wave.